Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02330926Phase 3Completed

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

Role: collaborator

NCT06428435Completed

Next Generation Home Vision Assessment

Role: lead

NCT06624397Not ApplicableRecruiting

Evaluation of a New Program for Carers of People with Anorexia Nervosa

Role: lead

NCT02138032Not ApplicableTerminated

Effects of Message Content on Intention to Quit Smoking

Role: collaborator

All 4 trials loaded